Related Experiment Video
Updated: Sep 18, 2025
Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice
Published on: August 4, 2011
Retinoma: An overview
Panagiotis N Toumasis1, Ashwin Mallipatna2,3, Timothy W Corson3,4
1School of Medicine National and Kapodistrian University of Athens Athens Greece.
Abstract:
Retinoma, also referred to as retinocytoma, is a benign manifestation of biallelic retinoblastoma gene (RB1) inactivation. Genetic or epigenetic loss of retinoblastoma protein in maturing cone precursors induces genomic instability which leads to upregulation of senescence-associated p16INK4a and p130, resulting in non-proliferative retinoma. When senescence pathways fail and genetic instability accumulates to a critical level through altered gene copies of oncogenes and tumor suppression genes, transformation into RB1 -/- retinoblastoma occurs. Thus, the management of retinoma involves frequent ophthalmic examination and imaging to monitor the size and characteristics of the tumor, ensure stability, and rule out malignant transformation. Key ophthalmoscopic features of retinoma often include a translucent whitish-gray retinal mass, calcification, retinal pigment epithelial alterations with well-defined margins, located typically around the lesion, as well as a zone of chorioretinal atrophy. This review aims to provide a comprehensive overview of this non-malignant tumor drawing from current understanding of its molecular genetics, clinical characteristics, diagnostic modalities, differential diagnosis, management, and prognosis. A deeper understanding of retinoma could offer valuable insights into how retinoblastoma develops and oncogenesis more broadly, paving the way for improved strategies to prevent and treat this malignant tumor.
Insights
Retinoma is a benign tumor caused by retinoblastoma gene (RB1) inactivation. Regular monitoring is crucial to detect any malignant transformation into retinoblastoma.
Area of Science:
- Ophthalmology
- Genetics
- Oncology
Background:
- Retinoma, or retinocytoma, is a benign tumor arising from biallelic inactivation of the retinoblastoma gene (RB1).
- Loss of retinoblastoma protein in cone precursors triggers genomic instability, leading to senescence and non-proliferative retinoma.
- Failure of senescence pathways and accumulated genetic alterations can result in malignant transformation to retinoblastoma.
Purpose of the Study:
- To provide a comprehensive review of retinoma.
- To elucidate the molecular genetics, clinical characteristics, diagnostics, and management of retinoma.
- To offer insights into retinoblastoma development and oncogenesis.
Main Methods:
- Review of current literature on retinoma.
- Analysis of molecular genetics and pathogenesis.
- Compilation of clinical features, diagnostic modalities, and management strategies.
Main Results:
- Retinoma presents as a translucent retinal mass with characteristic ophthalmoscopic features including calcification and RPE alterations.
- Management involves vigilant ophthalmic examination and imaging to monitor tumor stability and rule out malignant transformation.
- Understanding retinoma pathogenesis offers insights into retinoblastoma and broader oncogenesis.
Conclusions:
- Retinoma is a benign precursor lesion requiring careful monitoring for malignant transformation.
- Further understanding of retinoma can inform strategies for preventing and treating retinoblastoma.
- This review synthesizes current knowledge on retinoma, highlighting its significance in understanding ocular oncology.
Related Concept Videos
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:25Glaucoma: Overview
01:32The Retina
01:20Anatomy of the Eyeball